Clinical Trial Update: A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing entecavir to lamivudine in adults with chronic hepatitis B who are HBeAg-positive has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Epivir (Lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED